Collagen Type V Antikörper
-
- Target Alle Collagen Type V (COL5) Antikörper anzeigen
- Collagen Type V (COL5) (Collagen, Type V (COL5))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Collagen Type V Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Spezifität
- Reacts with conformational determinants on type V collagen Referenced species reactivities include - Human 2,5,6,11,13,14,17,23-26 Chicken 4 Porcine 1,5,8 Mouse 3,12,20 Cuttlefish 27 Rabbit 9,15 Rat 5,7,10,16 Equine 19,21,22 Tree Shrew 18 Canine 5 Guinea Pig 15
- Kreuzreaktivität (Details)
- Exhibits < 10 % cross reactivity with collagen type II, III, IV, V and VI. The antibody has not been tested for reactivity with other ECM proteins (e.g., laminin, fibronectin).
- Produktmerkmale
- Goat Anti-Type V Collagen-UNLB
- Aufreinigung
- Purification Method: Affinity chromatography on type V collagen covalently linked to agarose.
- Isotyp
- IgG
- Top Product
- Discover our top product COL5 Primärantikörper
-
-
- Applikationshinweise
-
- Applications: Quality tested applications include - ELISA ,
- Other referenced applications include - IHC-PS , IHC-FS , ICC , EM , WB
- Working Dilutions: ELISA BIOT conjugate 1:1,000 - 1:4,000
- Probenmenge
- 0,5 mL
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.4 mg/mL
- Buffer
- 0.2 mg of purified immunoglobulin in 0.5 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
- Konservierungsmittel
- Without preservative
- Handhabung
- Each reagent is stable for the period shown on the bottle label if stored as directed.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C
-
-
Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy." in: Nature communications, Vol. 10, Issue 1, pp. 2788, (2019) (PubMed).
: "A missense mutation in MYH1 is associated with susceptibility to immune-mediated myositis in Quarter Horses." in: Skeletal muscle, Vol. 8, Issue 1, pp. 7, (2018) (PubMed).
: "α3 Chains of type V collagen regulate breast tumour growth via glypican-1." in: Nature communications, Vol. 8, pp. 14351, (2018) (PubMed).
: "
-
Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy." in: Nature communications, Vol. 10, Issue 1, pp. 2788, (2019) (PubMed).
-
- Target
- Collagen Type V (COL5) (Collagen, Type V (COL5))
- Andere Bezeichnung
- Type V Collagen (COL5 Produkte)
-